Xcout Intel
MCAL Therapeutics Inc. competitors & alternatives
The 12 closest competitors and alternatives to MCAL Therapeutics Inc. among biotechnology companies — ranked by similarity to what MCAL Therapeutics Inc. actually does, not by market-cap band.
Subscribe to see MCAL Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About MCAL Therapeutics Inc.
MCAL Therapeutics Inc. is a biotechnology company developing synthetic, rabbit-inspired lipid eye drops and extended-release drug delivery platforms. Its lead candidate, MCAL-201, is designed to treat evaporative dry eye disease by restoring the tear film's protective lipid barrier.
MCAL Therapeutics Inc. at a glance
MCAL Therapeutics Inc. is a biotechnology company headquartered in United States. It has raised at least $6.3M across the 2 funding rounds on record. Its most recent funding round raised $5.9M in March 2024. Xcout tracks 7 named people at MCAL Therapeutics Inc., including Mary Newman (Chief Regulatory Officer).
MCAL Therapeutics Inc. leadership
- Mary NewmanChief Regulatory Officer
- Tom MatherChief Medical Officer
- Chuck O’NeillCEO, Co-Founder, Chair of the Board of Directors
- Chris MurphyCo-Founder and Expert in Corneal and Ocular Surface Diseases, Distinguished Professor of Comparative Ophthalmology Emeritus, University of California, Davis
- Tom GadekEmeritus Board Member and Co-Founder
- G. Eric DavisExecutive Vice President, Chief Legal Officer at BioMarin Pharmaceutical Inc.
1 more named person on record for MCAL Therapeutics Inc., with roles, board committees and tenure — see the full roster →
MCAL Therapeutics Inc. funding rounds
At least $6.3M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5.9M | — | |
| — | $450,000 | 14 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 MCAL Therapeutics Inc. competitors
Ranked by semantic similarity — how close each company is to MCAL Therapeutics Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Opal Biosciences (operating as Opal Therapeutics) is a biotechnology company that develops patient-derived uterine organoids to model human reproductive biology. The company provides research and drug discovery platforms to help researchers study conditions like endometriosis and uterine fibroids, serving the biotechnology and pharmaceutical research sectors.
Biotech
Relation Therapeutics Inc. is an active for-profit biotechnology company founded in 2019 that focuses on therapeutic development.
Similar biotechnology company
Maxwell Biosciences, Inc. is a biotechnology company based in Austin, Texas. It develops biomimetic, peptide-inspired anti-infective drugs designed to act as a synthetic immune system.
Similar biotechnology company
Tasca Therapeutics is a biotechnology research company based in Cambridge, Massachusetts, leveraging a unique platform to exploit lipid-binding pockets on proteins.
Similar biotechnology company
Biora Therapeutics is a U.S. biotechnology company developing ingestible, device-based platforms for delivering biologic medicines to targeted areas of the gastrointestinal tract and into systemic circulation. Its technologies are intended for use by pharmaceutical and biotechnology companies developing oral or targeted biologic therapies.
Similar biotechnology company
Scala Biodesign develops computational protein design technologies to optimize enzymes, antibodies, therapeutic proteins, and antigens for industries such as pharmaceuticals and chemicals.
Similar biotechnology company
MilanaPharm, LLC is a biotechnology company that develops drug delivery platforms and pharmaceutical products, including topical and local formulations such as Analgea SR and XACIATO. The company focuses on innovative product development to improve patient quality of life in areas such as pain management and women's health.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Similar biotechnology company
Applied Molecular Transport was a United States biotechnology company that developed oral biologic medicines using a proprietary epithelial drug-delivery platform. Its programs targeted gastrointestinal and autoimmune diseases, serving patients with conditions such as inflammatory bowel disease.
Similar biotechnology company
RNAV8 Bio is a biotechnology research company focused on renovating mRNA function through structure, chemistry, and delivery.
Similar biotechnology company
Day Three Labs Inc. is a biotechnology and pharmaceutical formulation company based in Denver, Colorado, founded in 2021. The company specializes in nanodelivery technologies that enhance the bioavailability of cannabinoid and pharmaceutical compounds.
Life Sciences
Cajal Neuroscience (Cajal Therapeutics Inc.) is a biotechnology company headquartered in Seattle, Washington. The company is dedicated to advancing therapeutic pipelines in neuroscience research.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of MCAL Therapeutics Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for MCAL Therapeutics Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →